Epidemiology, Gate frames & Incidence/Prevalence Flashcards
What is the goal of epidemiology & basic equation used
Studying disease occurance in a population over time
(no. of ppl with disease) / (No. of ppl in the population)
What does numerator and denominator represent
Numerator is those with disease and prevalence is the study population sharing similar characteristics
Components of the Gate frame
Triangle - study population
Circle - EG and CG
Square - EGO and CGO
O - Outcome in square
Horizontal - One time measurement
Vertical arrow - Overtime measurement
What do you do when a numerical measure isn’tn converted into a categorical?
Calcultae the mean or median excluding c or d (No disease people from both EG and CG) as this assumes everyone has a disease
EGO and CGO acronym meaning
Exposure group occurance and Comparison group occurance
Incidence components
Easy to observe disease events measured over time via categorical measurments e.g. death
Clean measure but hard to measure as observation occurs overtime
Prevalence components
Disease occurance measured at one point in time when transition from non diseased to diseased is blurry viz categorical and numerical measures
Dirty measure (Affected by incidence, death and cure)
Easy to measure as it happens at one point in time
Prevalence pool
Leftover drizzle from incidence and size depends on drizzle rate and loss to death and cure
Prevalence pool
Leftover drizzle from incidence and size depends on drizzle rate and loss to death and cure
Direction of arrows for one point in time measurement
Horizontal
Direction of arrow for longitudinal study
Vertical
Direction of arrow for timeframe from the past - Prevalence study
Top left corner
Association (Comparing disease measures)
Intitialdisease occurance should be estimates of association
Relative risk
Ratio of occurance with no units
Relative risk = 1
No effect value - there’s no difference in the effect of E and C on outcome
Equation for Relative risk > 1
Relative risk increase = (RR -1) x 100
Equation for relative risk < 1
Relative risk reduction = (1-RR) x 100
Absolute risk difference
Difference in disease occurance with units and contains more information than RR
Absolute risk difference = zero
No risk difference thus no difference between EGO and CGO
Absolute risk difference < 0
Ideal risk difference
Absolute risk reduction
Absolute risk is lower in EG
Absolute risk increase
Absolute risk is greater in EG
Randomised control trial key components
Study the effects of ethical and practical treatments
by random allocation into EG and CG via experiments
Rarely used to discover risk factors instead more in placebo studies
Long term RCT
Harmful treatment can be used as the test is now only observational but difficult to do well due to maintenance
Randomised control trial strengths
- minimise cofounding
- measures incidence and prevalence
- ensures participants in EG and CG are similar
Randomised control trial weaknesses
- Hard to recruit representative eager participants
- A-lot of maintenance error
- Very expensive and too small
- Too small produce insufficient results due to expensive conduct
Non random error
Errors in study design, poor ramboman